Moab Capital Partners’s Immunomedics Inc IMMU Stock Holding History

Moab Capital Partners’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-125,985	Closed	-$10.7M	–	18
2020 Q3	$10.7M	Buy	+125,985	New	+$6.37M	9.48%	4

Moab Capital Partners's IMMU Position: Q4 2020 in Review

Moab Capital Partners sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 125,985 shares — an estimated $10.7M sold.

Moab Capital Partners first reported a position in IMMU in Q3 2020 and held it in 1 quarter. The position peaked at $10.7M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Moab Capital Partners reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Moab Capital Partners sold 125,985 Immunomedics Inc shares in Q4 2020, an estimated $10.7M.
Moab Capital Partners first reported a position in Immunomedics Inc in Q3 2020 and held it in 1 quarter.
Moab Capital Partners's Immunomedics Inc position peaked at $10.7M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Moab Capital Partners's 13F filing for Q4 2020, filed 16 Feb 2021.